OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) - OREXIGEN THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

OREXIGEN THERAPEUTICS INC's ticker is OREXQ and the CUSIP is 686164302. A total of 4 filers reported holding OREXIGEN THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) ownership history of OREXIGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2018$0–33,3330.0%0.00%–
Q4 2017$0–33,3330.0%0.00%–
Q3 2017$0–33,3330.0%0.00%–
Q2 2017$0–33,3330.0%0.00%–
Q1 2017$0–33,333–0.00%–
 Download
Other shareholders

There were no reported owners of OREXIGEN THERAPEUTICS INC in Q2 2018.

NameSharesValueWeighting ↓
View complete list of OREXIGEN THERAPEUTICS INC shareholders